Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Spinosyn formulations for treatment of Demodex-induced ocular and facial conditions

Spinosyn formulations for treatment of Demodex-induced ocular and facial conditions

US Patent 11254701 · Granted Feb 22, 2022

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Spinosyn formulations for treatment of demodex-induced ocular and facial conditi2020
Spinosyn formulations for treatment of demodex-induced ocular and facial conditi2020
Spinosyn formulations for treatment of demodex-induced ocular and facial conditi2020
Method of making patient specific anti-idiotype antibodies2019
Methods for producing high-fidelity autologous idiotype vaccines2017
Method of identifying patients not suitable for high-dose cyclophosphamide treat2016
Methods for providing a system of care for a high-dose oxazaphosphorine drug reg2015
Cyclophosphamide in combination with anti-idiotypic vaccines2014